HIV prevention has advanced significantly over the past decade. One of the most effective tools available today is PrEP, short for pre-exposure prophylaxis. At Healthcare Unity Group (HUG), serving Melbourne, FL, Kearny, NJ, and telehealth communities, patient education around PrEP helps individuals understand how this medication works, who may benefit from it, and what to expect with ongoing monitoring.
PrEP is powerful prevention—but understanding how it works in real life makes it even more empowering. When taken consistently, PrEP can reduce the risk of acquiring HIV through sex by about 99% and significantly reduce risk from injection drug use. Knowing the science behind it and the practical steps involved can help people decide whether it fits into their health plan.
What Is PrEP?
PrEP is a prescription medication taken by individuals who do not have HIV but want to reduce their risk of acquiring it. Unlike HIV treatment, which is used after infection, PrEP is preventive. It is designed for people who may be at higher risk due to sexual activity, a partner living with HIV, or injection drug use.
Most commonly, PrEP involves a daily oral medication containing antiretroviral drugs. There are also long-acting injectable options available in certain settings. These medications have been extensively studied and shown to be safe and highly effective when used as directed.
If you want an overview of available options and monitoring, reviewing PrEP Services can help clarify how prevention programs are structured, including lab work and routine follow-up.
How PrEP Works in the Body
To understand how PrEP prevents HIV, it helps to know how HIV infection occurs. When HIV enters the body, it targets immune cells—specifically CD4 cells—and begins replicating. Antiretroviral medications interfere with this replication process.
PrEP medications maintain a steady level of antiviral drugs in the bloodstream and tissues. If HIV enters the body, these medications block the virus from establishing a permanent infection. Essentially, PrEP creates a protective barrier at the cellular level.
However, protection depends on adherence. For oral PrEP, consistent daily use is critical to maintain effective drug levels. Missing doses reduces the protective effect. Injectable PrEP options work differently by maintaining medication levels over a longer period, but timely follow-up injections are essential.
Who Should Consider PrEP?
PrEP is recommended for individuals who are HIV negative and at increased risk for exposure. This may include:
- Men who have sex with men
- Individuals with an HIV-positive partner
- People with multiple sexual partners
- Those who do not consistently use condoms
- Individuals diagnosed with other sexually transmitted infections
- People who inject drugs and share equipment
PrEP is appropriate for adults and adolescents weighing at least 35 kilograms (77 pounds). It is inclusive of all genders and sexual orientations, including members of the LGBTQ+ community.
Even if someone is unsure whether they qualify, discussing personal risk factors with a healthcare professional can clarify whether PrEP is a reasonable option.
The First Step: HIV Testing and Baseline Labs
Before starting PrEP, it is essential to confirm that the individual does not have HIV. Taking PrEP while unknowingly HIV positive can lead to drug resistance. For that reason, HIV testing is always performed before initiating medication.
Learning about Free Rapid HIV Testing can help individuals understand how initial screening works. In addition to HIV testing, baseline labs typically include kidney function tests and screening for other sexually transmitted infections. In some cases, hepatitis B testing is also performed because certain PrEP medications affect hepatitis B management.
This baseline evaluation ensures that PrEP is safe and appropriate.
What Happens After Starting PrEP?
Starting PrEP is not a one-time event. Ongoing monitoring is part of safe and effective use. Most guidelines recommend follow-up visits every three months for individuals taking daily oral PrEP.
During follow-up appointments, healthcare providers typically:
- Perform repeat HIV testing
- Review medication adherence
- Monitor kidney function (for oral PrEP)
- Screen for other STIs as needed
- Discuss any side effects or concerns
These regular visits ensure that the medication continues to work as intended and that overall sexual health is addressed comprehensively.
How Effective Is PrEP?
When taken consistently, daily oral PrEP reduces the risk of HIV transmission through sexual contact by approximately 99%. For injection drug use, risk reduction is estimated at at least 74% with consistent adherence. Injectable PrEP has also demonstrated high effectiveness when administered on schedule.
It is important to note that PrEP does not protect against other sexually transmitted infections. For that reason, comprehensive sexual health strategies—including condom use and routine STI screening—remain important.
For individuals who may have concerns about other infections, understanding STI Testing and Treatment provides context for why combined prevention strategies are often recommended.
Side Effects and Safety
PrEP medications are generally well-tolerated. Some individuals may experience mild side effects such as nausea, headache, or gastrointestinal discomfort during the first few weeks. These symptoms often resolve as the body adjusts.
Long-term safety has been extensively studied. Oral PrEP medications may affect kidney function or bone density in a small percentage of individuals, which is why regular lab monitoring is part of follow-up care. Injectable PrEP may cause mild injection site reactions.
Open communication with a healthcare provider ensures that any side effects are addressed promptly and that alternative options can be considered if needed.
PrEP and Real-Life Prevention Planning
PrEP works best as part of a broader prevention strategy tailored to individual circumstances. Some people use PrEP during periods of higher risk—such as new relationships—and discontinue when risk decreases. Others use it continuously for ongoing protection.
For individuals in relationships where one partner is living with HIV, PrEP can provide additional reassurance, particularly if the partner has not yet achieved viral suppression. Modern HIV Treatment Services enable people living with HIV to reach undetectable viral loads, eliminating sexual transmission risk. Together, treatment and PrEP form a powerful prevention partnership.
Prevention planning is personal. It involves open discussions about lifestyle, goals, and comfort levels. The goal is not perfection—it is informed protection.
PrEP Is Empowerment
PrEP has reshaped what HIV prevention looks like in everyday life. Instead of relying on a single strategy, individuals now have access to science-backed tools that offer meaningful protection when used consistently and monitored appropriately.
By understanding how PrEP works, why regular lab testing matters, and how it fits into a broader prevention plan, people can make informed decisions about their sexual health. At Healthcare Unity Group (HUG), with locations in Melbourne, FL, and Kearny, NJ, as well as telehealth access, the focus remains on clear education and thoughtful guidance so prevention feels practical, personalized, and within reach.
Sources
Grant, R.M., et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine.
Baeten, J.M., et al. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine.
Landovitz, R.J., et al. (2021). Cabotegravir for HIV prevention in cisgender men and transgender women. New England Journal of Medicine.
